Literature DB >> 10873974

In vitro antibiotic resistance in bacterial keratitis in London.

S J Tuft1, M Matheson.   

Abstract

AIM: To document changes in the profile of bacterial isolates from cases of keratitis and changes in their susceptibility to first line antibiotic therapies.
METHODS: A retrospective review was performed of all bacterial isolates from cases of keratitis seen between 1984 and 1999. In vitro laboratory susceptibilities to antibiotics were determined by the Kirby-Bauer disc diffusion method. The number of isolates, changes in the proportion of bacterial types, and the number that were fully resistant to monotherapy (ofloxacin), dual therapy (gentamicin and cefuroxime), and prophylactic treatment (chloramphenicol) were calculated.
RESULTS: There were 1312 bacterial isolates over 16 years. Gram positive bacteria accounted for 54.7% of isolates and Staphylococcus species (33.4%) were the most frequently isolated organisms. During the study period there has been an increase in the proportion of Pseudomonas species isolates but no overall increase in the proportion of Gram negative isolates. There has not been an increase in the proportion of isolates resistant to ofloxacin since 1995 or an increase in resistance to the combination of gentamicin and cefuroxime. However, since 1984 there has been a significant increase in proportion of Gram negative organisms resistant to chloramphenicol (p=0.0019).
CONCLUSIONS: An increase in the in vitro resistance of organisms to first line therapies for bacterial keratitis has not been observed. An increased resistance to chloramphenicol indicates that this drug is unlikely to provide prophylactic cover when Gram negative infection is a risk. Continued monitoring for the emergence of antibiotic resistance is recommended.

Entities:  

Mesh:

Year:  2000        PMID: 10873974      PMCID: PMC1723533          DOI: 10.1136/bjo.84.7.687

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  32 in total

Review 1.  Lack of evidence for systemic toxicity following topical chloramphenicol use.

Authors:  S Walker; C J Diaper; R Bowman; G Sweeney; D V Seal; C M Kirkness
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

2.  Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears.

Authors:  D B Jones
Journal:  Surv Ophthalmol       Date:  1979 Sep-Oct       Impact factor: 6.048

3.  Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.

Authors: 
Journal:  Ophthalmology       Date:  1997-11       Impact factor: 12.079

4.  Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms.

Authors:  J L Baum
Journal:  Surv Ophthalmol       Date:  1979 Sep-Oct       Impact factor: 6.048

5.  Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.

Authors:  M H Goldstein; R P Kowalski; Y J Gordon
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

6.  Ciprofloxacin-resistant Pseudomonas keratitis.

Authors:  P Garg; S Sharma; G N Rao
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

7.  Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.

Authors:  R A Hyndiuk; R A Eiferman; D R Caldwell; G O Rosenwasser; C I Santos; H R Katz; S S Badrinath; M K Reddy; J P Adenis; V Klauss
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

8.  Fluoroquinolones in the treatment of bacterial keratitis.

Authors:  K S Bower; R P Kowalski; Y J Gordon
Journal:  Am J Ophthalmol       Date:  1996-06       Impact factor: 5.258

9.  Differential care of corneal ulcers in the community based on apparent severity.

Authors:  S D McLeod; C M DeBacker; M A Viana
Journal:  Ophthalmology       Date:  1996-03       Impact factor: 12.079

10.  In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.

Authors:  D Y Kunimoto; S Sharma; P Garg; G N Rao
Journal:  Ophthalmology       Date:  1999-01       Impact factor: 12.079

View more
  13 in total

1.  Suppurative keratitis.

Authors:  S J Tuft
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Overview: Initial antimicrobial therapy for microbial keratitis.

Authors:  M Daniell
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  Response to Thyagarajan et al's audit: "An audit of corneal abrasion management following the introduction of local guidelines in an accident and emergency department.".

Authors:  A Day; G Carp
Journal:  Emerg Med J       Date:  2006-12       Impact factor: 2.740

4.  Initial therapy for suppurative microbial keratitis in Iraq.

Authors:  Faiz Al-Shakarchi
Journal:  Br J Ophthalmol       Date:  2007-06-27       Impact factor: 4.638

5.  In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.

Authors:  H O Orlans; S J Hornby; I C J W Bowler
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

6.  Bacterial spectrum and resistance patterns in corneal infections at a Tertiary Eye Care Center in South China.

Authors:  Nan Wang; Qiang Huang; Yi-Wei Tan; Li-Ping Lin; Kai-Li Wu
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

7.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24

8.  Clinical features of infectious keratitis at a tertiary referral center in a rural area of Korea.

Authors:  Seung-Jun Lee; Jang Hun Lee; Moosang Kim; Sang Beom Han; Joon Young Hyon
Journal:  Int Med Case Rep J       Date:  2015-12-07

9.  Spectrum of bacterial keratitis at a tertiary eye care centre in India.

Authors:  Jayaraman Kaliamurthy; Catti Muniswamy Kalavathy; Pragya Parmar; Christadas Arul Nelson Jesudasan; Philip A Thomas
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

10.  Spectrum and Sensitivity of Bacterial Keratitis Isolates in Auckland.

Authors:  S Marasini; S Swift; S J Dean; S E Ormonde; J P Craig
Journal:  J Ophthalmol       Date:  2016-04-26       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.